Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise
To test the hypothesis that delayed onset muscular soreness (DOMS) following intense eccentric muscle contraction could be due to increased production of prostaglandin E2 (PGE2), ten healthy male subjects were studied. Using a double-blind randomized crossover design, each subject performed two isok...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1996-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/S0962935196000336 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849686109048537088 |
|---|---|
| author | J-L. Croisier G. Camus T. Monfils G. Deby-Dupon M. Fafchamps I. Venneman J-M. Crielaard A. Juchmès-Ferir C. Lhermerout M. Lamy C. Deby |
| author_facet | J-L. Croisier G. Camus T. Monfils G. Deby-Dupon M. Fafchamps I. Venneman J-M. Crielaard A. Juchmès-Ferir C. Lhermerout M. Lamy C. Deby |
| author_sort | J-L. Croisier |
| collection | DOAJ |
| description | To test the hypothesis that delayed onset muscular soreness (DOMS) following intense eccentric muscle contraction could be due to increased production of prostaglandin E2 (PGE2), ten healthy male subjects were studied. Using a double-blind randomized crossover design, each subject performed two isokinetic tests separated by a period of at least 6 weeks: once with placebo, and once with piroxicam (Feldene®). They were given one capsule containing either placebo or piroxicam (20 mg) per day for 6 days with initial doses given starting 3 days prior to isokinetic testing. Exercise consisted of eight stages of five maximal contractions of the knee extensor and flexor muscle groups of both legs separated by 1 min rest phases, on a Kin Trex device at 60°/s angular velocity. The subjective presence and intensity of DOMS were evaluated using a visual analogue scale immediately after, and 24 and 48 h after each test. The mean plasma concentration of PGE2 measured at rest and after exercise was significantly lower in the group treated with piroxicam (p < 0.05). However, statistical analysis (two-way ANOVA test) revealed that exercise did not cause any significant change of mean plasma PGE2 over time in either of the two groups. Eccentric work was followed by severe muscle pain in extensor and flexor muscle groups. Maximal soreness was noted 48 h postexercise. Serum creatine kinase activity and the serum concentration of myoglobin increased significantly, and reached peak values 48 h after exercise in both experimental conditions (p < 0.001). By paired t-test, it appeared that there were no significant differences in the serum levels of these two markers of muscle damage between the two groups at any time point. We conclude that: (1) oral administration of piroxicam fails to reduce muscle damage and DOMS caused by strenuous eccentric exercise; and (2) the hypothetical role of increased PGE2 production in eccentric exercise-induced muscle damage, DOMS, and reduced isokinetic performance is not substantiated by the present results. |
| format | Article |
| id | doaj-art-b87f2e8c6f3e4d539398b7e20bcbc85b |
| institution | DOAJ |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 1996-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-b87f2e8c6f3e4d539398b7e20bcbc85b2025-08-20T03:22:49ZengWileyMediators of Inflammation0962-93511466-18611996-01-015323023410.1155/S0962935196000336Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exerciseJ-L. Croisier0G. Camus1T. Monfils2G. Deby-Dupon3M. Fafchamps4I. Venneman5J-M. Crielaard6A. Juchmès-Ferir7C. Lhermerout8M. Lamy9C. Deby10Department of Physical Medicine and Rehabilitation, Institute of Chemistry, BelgiumCenter for the Biochemistry of Oxygen, Institute of Chemistry, BelgiumDepartment of Physical Medicine and Rehabilitation, Institute of Chemistry, BelgiumCenter for the Biochemistry of Oxygen, Institute of Chemistry, BelgiumDepartment of Physical Medicine and Rehabilitation, Institute of Chemistry, BelgiumDepartment of Anesthesiology and Intensive Care Medicine, ISEPK, BelgiumDepartment of Physical Medicine and Rehabilitation, Institute of Chemistry, BelgiumDepartment of Clinical Biology, CHU, University of Liège, Sart Tilman, Liège B-4000, BelgiumLaboratory of Human Applied Physiology, ISEPK, BelgiumCenter for the Biochemistry of Oxygen, Institute of Chemistry, BelgiumCenter for the Biochemistry of Oxygen, Institute of Chemistry, BelgiumTo test the hypothesis that delayed onset muscular soreness (DOMS) following intense eccentric muscle contraction could be due to increased production of prostaglandin E2 (PGE2), ten healthy male subjects were studied. Using a double-blind randomized crossover design, each subject performed two isokinetic tests separated by a period of at least 6 weeks: once with placebo, and once with piroxicam (Feldene®). They were given one capsule containing either placebo or piroxicam (20 mg) per day for 6 days with initial doses given starting 3 days prior to isokinetic testing. Exercise consisted of eight stages of five maximal contractions of the knee extensor and flexor muscle groups of both legs separated by 1 min rest phases, on a Kin Trex device at 60°/s angular velocity. The subjective presence and intensity of DOMS were evaluated using a visual analogue scale immediately after, and 24 and 48 h after each test. The mean plasma concentration of PGE2 measured at rest and after exercise was significantly lower in the group treated with piroxicam (p < 0.05). However, statistical analysis (two-way ANOVA test) revealed that exercise did not cause any significant change of mean plasma PGE2 over time in either of the two groups. Eccentric work was followed by severe muscle pain in extensor and flexor muscle groups. Maximal soreness was noted 48 h postexercise. Serum creatine kinase activity and the serum concentration of myoglobin increased significantly, and reached peak values 48 h after exercise in both experimental conditions (p < 0.001). By paired t-test, it appeared that there were no significant differences in the serum levels of these two markers of muscle damage between the two groups at any time point. We conclude that: (1) oral administration of piroxicam fails to reduce muscle damage and DOMS caused by strenuous eccentric exercise; and (2) the hypothetical role of increased PGE2 production in eccentric exercise-induced muscle damage, DOMS, and reduced isokinetic performance is not substantiated by the present results.http://dx.doi.org/10.1155/S0962935196000336 |
| spellingShingle | J-L. Croisier G. Camus T. Monfils G. Deby-Dupon M. Fafchamps I. Venneman J-M. Crielaard A. Juchmès-Ferir C. Lhermerout M. Lamy C. Deby Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise Mediators of Inflammation |
| title | Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise |
| title_full | Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise |
| title_fullStr | Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise |
| title_full_unstemmed | Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise |
| title_short | Piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise |
| title_sort | piroxicam fails to reduce myocellular enzyme leakage and delayed onset muscle soreness induced by isokinetic eccentric exercise |
| url | http://dx.doi.org/10.1155/S0962935196000336 |
| work_keys_str_mv | AT jlcroisier piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT gcamus piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT tmonfils piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT gdebydupon piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT mfafchamps piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT ivenneman piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT jmcrielaard piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT ajuchmesferir piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT clhermerout piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT mlamy piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise AT cdeby piroxicamfailstoreducemyocellularenzymeleakageanddelayedonsetmusclesorenessinducedbyisokineticeccentricexercise |